Merck & Co Inc (NYSE:MRK)
| 81.07 Delayed Data As of 5:52pm ET |  +1.58 / +1.99%Today’s Change | 68.38 Today|||52-Week Range 84.56 | +3.94% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 79.49 |
| Today’s open | 79.29 |
| Day’s range | 79.29 - 81.24 |
| Volume | 11,465,505 |
| Average volume (3 months) | 12,826,159 |
| Market cap | $198.3B |
Data as of 5:52pm ET, 10/20/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | -0.78% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 33.1 |
| Price/Sales | 4.33 |
| Price/Book | 7.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.99 | +0.92% |
| AZNAstraZeneca | +0.46 | +0.76% |
| NVSNovartis | +1.33 | +1.60% |
| NVONovo Nordisk | -0.11 | -0.11% |
Data as of 4:01pm ET, 10/20/2021
Financials
| Next reporting date | October 28, 2021 |
| EPS forecast (this quarter) | $1.53 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
